Catalyst and Walgreen Co. Announce Early Termination of Hart-Scott-Rodino Act Waiting Period

Published in Business and Finance on Monday, March 28th 2011 at 14:20 GMT by Market Wire
^{🞛 This publication is a summary or evaluation of another publication}

ROCKVILLE, Md. & DEERFIELD, Ill.--([ BUSINESS WIRE ])--Catalyst Health Solutions, Inc. (NASDAQ:CHSI) and Walgreen Co. (NYSE, NASDAQ: WAG) announced that the Federal Trade Commission (FTC) has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with Catalysta�s previously announced proposed acquisition of Walgreens Health Initiatives, Inc., the pharmacy benefit management subsidiary of Walgreen Co.

Completion of the proposed acquisition remains subject to other closing conditions. The companies continue to expect to complete the transaction in the first half of calendar 2011.

About Catalyst Health Solutions, Inc.

Catalyst Health Solutions, Inc., the fastest growing national PBM in the U.S., is built on strong, innovative principles in the management of prescription drug benefits and provides an unbiased, client-centered philosophy resulting in industry-leading client retention rates. The Company's subsidiaries include Catalyst Rx, a full-service pharmacy benefit manager (PBM) serving more than 7 million lives in the United States and Puerto Rico; HospiScript Services, LLC, one of the largest providers of PBM services to the hospice industry; FutureScripts, LLC, a full-service PBM serving approximately one million lives in the mid-Atlantic region, and Immediate Pharmaceutical Services, Inc., a fully integrated prescription mail service facility in Avon Lake, Ohio. The Company's clients include self-insured employers, including state and local governments, managed care organizations, unions, hospices, third-party administrators and individuals.

About Walgreen Co.

Walgreens ([ www.walgreens.com ]) is the nation's largest drugstore chain with fiscal 2010 sales of $67 billion. The company operates 7,689 drugstores in all 50 states, the District of Columbia and Puerto Rico. Each day, Walgreens provides nearly 6 million customers the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice in communities across America. Walgreens scope of pharmacy services includes retail, specialty, infusion, medical facility and mail service, along with respiratory services. These services improve health outcomes and lower costs for payers including employers, managed care organizations, health systems, pharmacy benefit managers and the public sector. Take Care Health Systems is a Walgreens subsidiary that is the largest and most comprehensive manager of worksite health centers and in-store convenient care clinics, with more than 700 locations throughout the country.

Forward Looking Statements

This press release may contain aforward-looking statementsa as defined in the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties that might materially affect our results, particularly those risks referred to in our Annual Report on Form 10-K for the year ended December 31, 2010, under aItem 1A. Risk Factors.a Readers are urged to carefully review and consider the various disclosures made in our Annual Report on Form 10-K, our Forms 10-Q, and our other filings with the Securities and Exchange Commission that attempt to advise interested parties of the risks and uncertainties that may affect our business. Catalyst Health Solutions, Inc. does not undertake any obligation to update forward-looking statements, whether as a result of new information, future events, or other developments.

Photos/MultimediaGallery Available: [ http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6662385&lang=en ]

Publication Contributing Sources

Market Wire

N🟁N

Catalyst and Walgreen Co. Announce Early Termination of Hart-Scott-Rodino Act Waiting Period